Close Menu

NEW YORK (GenomeWeb) – Quanterix said today that it has closed its initial public offering, selling more than 4.9 million shares of common stock at $15 per share, raising $73.7 million in gross proceeds. Its shares now trade on the Nasdaq under ticker symbol QTRX.

In early afternoon trading, the company's stock was up about 5 percent at $19.08 per share.

JP Morgan Securities, Leerink Partners, and Cowen were joint book-running managers for the offering, while BTIG and Evercore Group were comanagers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.